Metabolix Inc (NASDAQ:MBLX)
| 0.43 Data as of Jan 23 |  +0.01 / +2.38%Today’s Change | 0.25 Today|||52-Week Range 1.67 | +4.47% Year-to-Date |
| SECTOR Process Industries | INDUSTRY Chemicals: Specialty | MARKET CAP $58.1M |
Company Description
Metabolix, Inc. is a bioscience company which delivers sustainable solutions to the plastics, chemicals, and energy industries. It operates through single segment, which is the business of developing and commercializing technologies for the production of polymers and chemicals in plants and in microbes. The company is developing and commercializing Mirel and Mvera, a family of bioplastics which are biobased and biodegradable alternatives to many petroleum-based plastics. It is also developing a platform for co-producing plastics, chemicals and energy from crops. The company targets its products in four market segments: Agriculture/Horticulture, Compost & Organic Waste Diversion, Marine & Aquatic, and Sustainable Packaging. Metabolix was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Cambridge, MA.
Contact Information
Metabolix, Inc. 21 Erie Street Cambridge Massachusetts 02139-4260 |
Employees
Shareholders
| Individual stakeholders | 66.75% |
| Other institutional | 5.60% |
| Mutual fund holders | 1.79% |
Top Executives
| Joseph H. Shaulson | President, Chief Executive Officer & Director |
| Johan van Walsem | Chief Operating Officer |
| Charles B. Haaser | Controller, Chief Financial & Accounting Officer |
| Oliver P. Peoples | Director & Chief Scientific Officer |
| Max Senechal | Vice President-Biobased Chemicals |
.